SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is trending as the community rallies around OG memes and a desire to recapture the 2021 vibe in the crypto space. Fueling the conversation is anticipation for upcoming community spaces and a push for moonshot listings. The focus remains on community building and the resurgence of classic internet culture.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending amid discussions about its upcoming earnings report and potential catalysts related to its AI data center business. The community is analyzing the stock's technical indicators and expressing varied opinions on its short-term price action following news of a significant investment. Some traders are anticipating a strong earnings report while others are cautious, citing previous 'sell the news' events, but many express confidence in GLXY's long-term potential due to its positioning in both the crypto and AI sectors.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is experiencing significant volatility, triggering heated debates about whether its recent pullback signals a buying opportunity or a deeper correction. Community members are actively discussing potential support levels and the impact of broader market sentiment, particularly as gold's movements are weighed against equities and crypto. Some traders speculate on manipulation and potential rotation into other assets amid concerns about overbought conditions.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Minerva Neurosciences Inc

Minerva Neurosciences ($NERV) is trending amid high volatility and speculation surrounding an upcoming FDA decision on their schizophrenia drug, expected soon. Bullish investors anticipate approval due to unmet needs and are drawing parallels to recent acquisitions in the CNS space, while bears express concerns about trial data and potential rejection. Community members are actively discussing the potential for a short squeeze and comparing the stock to other high-performing biotech companies.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices experience significant volatility, with community members debating whether a top is in or if this is a buying opportunity. Discussions revolve around potential manipulation, supply shortages, and the impact of global economic factors. Many are watching for a breakout above key resistance levels, while others express concern about a possible pullback.

GSI Technology, Inc. engages in the design, development and marketing of memory products primarily for the networking, and telecommunications markets. Its product includes Static Random Access Memory, or SRAM, which incorporated in networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations and network access equipment. It also offers services to the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs .The company was founded by Lee-Lean Shu and Robert Yau in March 1995 and is headquartered in Sunnyvale, CA.

GSI Technology Inc

GSIT is trending due to a Cornell study validating its Gemini APU's AI performance with significantly lower energy consumption compared to GPUs, sparking excitement about its potential in the $100B AI inference market. The community is actively discussing the possibility of a buyout from a major player like NVDA and the potential for a short squeeze, despite news of a recent offering. Some are drawing parallels to other high-flying AI-related stocks and anticipating significant upside based on the disruptive nature of the technology.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is trending following an earnings report, with community members discussing tariff impacts, EV strategy adjustments, and raised guidance. Some believe GM is undervalued compared to TSLA, while others criticize vehicle quality and pricing. Discussions also include potential short squeezes and institutional ownership.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs ($CLF) is trending as traders react to the company's announced exploration into rare earth mineral production, a move seen as a potential shift toward strategic metals. The community is debating the feasibility and impact of this new venture, especially given the company's existing debt and the CEO's track record, while some analysts have downgraded the stock.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is trending amid speculation of a potential acquisition, with community members discussing possible buyout prices and interested parties like Netflix and Comcast. The company's openness to a sale has sparked a review of strategic alternatives, intensifying speculation and driving trading action. Community chatter also highlights the potential for a bidding war, with some suggesting the company's content library warrants a higher valuation.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

DIA is trending amid concerns over potential US-China trade escalations following Trump's tariff threats and China's responses, leading to market uncertainty. The community is closely watching for any signs of de-escalation or further trade restrictions, with some anticipating a market correction. Despite this, many investors see opportunities and highlight the underlying strength of the Dow.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What’s the role of generative AI in drug discovery?

Investing.com -- Generative AI is emerging as a transformative long-term force in drug discovery, a field historically characterized by lengthy timelines, high costs, and low success rates.

Acrivon Therapeutics, Inc.: A Strong Buy on Robust Clinical Prospects and Financial Stability

JMP Securities analyst Silvan Tuerkcan has maintained their bullish stance on ACRV stock, giving a Buy rating yesterday. Silvan Tuerkcan's rating i...

Acrivon Therapeutics, Inc.: Strong Buy Rating on Robust Financials and Promising Clinical Data

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Acrivon Therapeutics, Inc. (ACRV Research Report), with a pri...

Acrivon Therapeutics Stock Is Soaring Tuesday: What's Going On?

Acrivon Therapeutics has entered into a securities purchase agreement to issue and sell 8.235 million shares of its common stock at a price of $8.50 per share, as well as pre-funded warrants to...

12 titres de soins de sant  en mouvement lors de la pr -ouverture le 09/04/2024

Gagnants
Le titre Acrivon Therapeutics (NASDAQ:ACRV) a mont mardi de 75,12% 10,35 dollars lors de la session pre-market.
Le titre Biophytis (NASDAQ:BPTS) a augment de 40,48% 0,45 dollars.
Le...

12 titres de soins de sant  en mouvement lors de la session du 09/04/2024

Gagnants
L'action Acrivon Therapeutics (NASDAQ:ACRV) a grimp mardi de 73,43% 10,25 dollars lors de la session ordinaire.
L'action BioSig Technologies (NASDAQ:BSGM) a augment de 24,20% 1,54...

BMO Capital Markets Reiterates Outperform Rating for Acrivon Therapeutics (NASDAQ:ACRV)

Acrivon Therapeutics (NASDAQ:ACRV - Get Free Report)s stock had its "outperform" rating restated by stock analysts at BMO Capital Markets in a research report issued on Monday, Benzinga...

Buy Rating on Acrivon Therapeutics: Anticipated Clinical Validation and Strong Financial Position

Silvan Tuerkcan, an analyst from JMP Securities, maintained the Buy rating on Acrivon Therapeutics, Inc. (ACRV Research Report). The associated p...

Short Interest in Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Increases By 22.7%

Acrivon Therapeutics, Inc. (NASDAQ:ACRV - Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 484,000 shares, a growth...

Acrivon Therapeutics (NASDAQ:ACRV) Receives "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Acrivon Therapeutics (NASDAQ:ACRV - Free Report) in a research report report published on Thursday, Benzinga reports. HC Wainwright currently has...

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.

Acrivon Therapeutics Inc

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$1.92
Prev Close	$1.92
Open	$1.94
Dividend Yield	0.00%
50-Day Moving Average	$1.58
Beta	0.00
Avg. Volume	3.46M
PE Ratio	-0.86

52-Week High	$8.74
52-Week Low	$1.05
Market Capitalization	$60.39M
EPS (Annual)	-$2.38
Price to Book	0.42
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ACRV
ACRIVON THERAPEUTICS INC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACRV News

ACRVACRIVON THERAPEUTICS INC